🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Investigational Drug Gaining Popularity Online

The experimental drug, which is still in research studies, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are urged to message these accounts directly for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers promote the substance there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Professionals Express Worries

However, doctors and chemists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could result in individuals administering substances of unknown origin.

Some experts stated the popularity for the experimental drug could be linked to the rising cost of licensed weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several influencers try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach medicines, marketing, and customer laws, potentially leading to penalties, legal action or prison.

Platform Reaction and Content Elimination

According to TikTok, the service has taken down violative content and prohibited related keywords and query recommendations. The organization said it was dedicated to keeping the platform safe and investing in strengthening compliance measures.

Digital Marketplace Operations

Research also discovered groups with up to nine thousand members selling the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with numerous of users, filled with photos of weight loss, glowing reviews and step-by-step guides for preparing or injecting at residence.

After moments of joining one community, a vendor shared WhatsApp details, where most purchases occur. The seller sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about body mass, health issues or past usage.

Item Details and Pricing

Inside these groups, messages show black plastic parcels with postal service stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with sterile water, or pre-filled pens typically sold at 160 pounds for 20mg. When asked how long a pen should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram stated it actively moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting materials they cannot confirm. Even if the science behind this drug is sound, these digital products may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But fake injections are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.

Her team has previously seen individuals injured by personal administration from unverified sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company investigational substance not yet approved … may expose users to possibly significant medical dangers”.